Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis)
28 August 2018 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Aarhus University Hospital, Aarhus (Denmark)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
08:30 CET
